サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1316801

バイオプロセスバリデーション市場：試験タイプ、プロセスコンポーネント、エンドユーザー別-2023-2030年の世界予測

Bioprocess Validation Market by Test Type, Process Component, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオプロセスバリデーション市場：試験タイプ、プロセスコンポーネント、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオプロセスバリデーションの世界市場は、2023年に3億9,547万米ドル、CAGR14.76%で大きく成長し、2030年には10億3,834万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のバイオプロセスバリデーション市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.バイオプロセスバリデーションの世界市場規模および予測は？

2.予測期間中、世界のバイオプロセスバリデーション市場を形成するCOVID-19の阻害要因と影響は？

3.バイオプロセスバリデーションの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.バイオプロセスバリデーションの世界市場における競争戦略は？

5.バイオプロセスバリデーションの世界市場における技術動向と規制の枠組みは？

6.バイオプロセスバリデーションの世界市場における主要ベンダーの市場シェアは？

7.バイオプロセスバリデーションの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 正確な安全性と品質規制
      • バイオ医薬品の需要の高まり
      • アウトソーシングのニーズの高まりバイオプロセスバリデーション
    • 抑制要因
      • バイオプロセスバリデーションのコストが高い
    • 機会
      • 次世代バイオ製品の新たな検証手法の開発
      • ヘルスケア分野における細胞および遺伝子治療の出現
    • 課題
      • 検証プロセスの機能上の問題
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 バイオプロセスバリデーション市場テストタイプ別

  • 互換性テストサービス
  • 抽出物または浸出物の試験サービス
  • 完全性テストサービス
  • 微生物検査サービス

第7章 バイオプロセスバリデーション市場プロセスコンポーネント別

  • バイオリアクター
  • フィルター要素
  • 冷凍・解凍処理用バッグ
  • メディアコンテナとバッグ
  • 混合システム
  • 搬送システム

第8章 バイオプロセスバリデーション市場：エンドユーザー別

  • バイオテクノロジー企業
  • 受託開発・製造組織
  • 製薬会社

第9章 南北アメリカのバイオプロセスバリデーション市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のバイオプロセスバリデーション市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのバイオプロセスバリデーション市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BIOPROCESS VALIDATION MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPROCESS VALIDATION MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BIOPROCESS VALIDATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
  • FIGURE 5. BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2022 VS 2030 (%)
  • FIGURE 6. BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 7. BIOPROCESS VALIDATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. BIOPROCESS VALIDATION MARKET DYNAMICS
  • FIGURE 9. BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. BIOPROCESS VALIDATION MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. BIOPROCESS VALIDATION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BIOPROCESS VALIDATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BIOPROCESS VALIDATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. BIOPROCESS VALIDATION MARKET SIZE, BY COMPATIBILITY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPROCESS VALIDATION MARKET SIZE, BY EXTRACTABLES OR LEACHABLES TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOPROCESS VALIDATION MARKET SIZE, BY INTEGRITY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BIOPROCESS VALIDATION MARKET SIZE, BY MICROBIOLOGICAL TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 10. BIOPROCESS VALIDATION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BIOPROCESS VALIDATION MARKET SIZE, BY FILTER ELEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOPROCESS VALIDATION MARKET SIZE, BY FREEZING & THAWING PROCESS BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BIOPROCESS VALIDATION MARKET SIZE, BY MEDIA CONTAINERS & BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOPROCESS VALIDATION MARKET SIZE, BY MIXING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BIOPROCESS VALIDATION MARKET SIZE, BY TRANSFER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. BIOPROCESS VALIDATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. BIOPROCESS VALIDATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BIOPROCESS VALIDATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. BIOPROCESS VALIDATION MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 148. BIOPROCESS VALIDATION MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 149. BIOPROCESS VALIDATION MARKET LICENSE & PRICING
目次
Product Code: MRR-4316E4E891C1

The Global Bioprocess Validation Market is forecasted to grow significantly, with a projected USD 395.47 million in 2023 at a CAGR of 14.76% and expected to reach a staggering USD 1,038.34 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Bioprocess Validation Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Bioprocess Validation Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Test Type, market is studied across Compatibility Testing Services, Extractables or Leachables Testing Services, Integrity Testing Services, and Microbiological Testing Services. The Integrity Testing Services is projected to witness significant market share during forecast period.

Based on Process Component, market is studied across Bioreactors, Filter Elements, Freezing & Thawing Process Bags, Media Containers & Bags, Mixing Systems, and Transfer Systems. The Bioreactors is projected to witness significant market share during forecast period.

Based on End User, market is studied across Biotechnology Companies, Contract Development & Manufacturing Organizations, and Pharmaceutical Companies. The Contract Development & Manufacturing Organizations is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Bioprocess Validation Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Bioprocess Validation Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bioprocess Validation Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bioprocess Validation Market?

4. What is the competitive strategic window for opportunities in the Global Bioprocess Validation Market?

5. What are the technology trends and regulatory frameworks in the Global Bioprocess Validation Market?

6. What is the market share of the leading vendors in the Global Bioprocess Validation Market?

7. What modes and strategic moves are considered suitable for entering the Global Bioprocess Validation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Bioprocess Validation Market, by Test Type, 2022 vs 2030
  • 4.3. Bioprocess Validation Market, by Process Component, 2022 vs 2030
  • 4.4. Bioprocess Validation Market, by End User, 2022 vs 2030
  • 4.5. Bioprocess Validation Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Precise safety and quality regulations
      • 5.1.1.2. Rising demand for biopharmaceuticals
      • 5.1.1.3. Growing need for outsourcing bioprocess validation
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of bioprocess validation
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of new validation methods for next-generation bioproducts
      • 5.1.3.2. Emergence of cell & gene therapy in the healthcare sector
    • 5.1.4. Challenges
      • 5.1.4.1. Functional issues with validation processes
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Bioprocess Validation Market, by Test Type

  • 6.1. Introduction
  • 6.2. Compatibility Testing Services
  • 6.3. Extractables or Leachables Testing Services
  • 6.4. Integrity Testing Services
  • 6.5. Microbiological Testing Services

7. Bioprocess Validation Market, by Process Component

  • 7.1. Introduction
  • 7.2. Bioreactors
  • 7.3. Filter Elements
  • 7.4. Freezing & Thawing Process Bags
  • 7.5. Media Containers & Bags
  • 7.6. Mixing Systems
  • 7.7. Transfer Systems

8. Bioprocess Validation Market, by End User

  • 8.1. Introduction
  • 8.2. Biotechnology Companies
  • 8.3. Contract Development & Manufacturing Organizations
  • 8.4. Pharmaceutical Companies

9. Americas Bioprocess Validation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bioprocess Validation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bioprocess Validation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing